Urine concentrating defect as presenting sign of progressive renal failure in Bardet–Biedl syndrome patients

• Published in: Clinical Kidney Journal 2021-06, Vol.14 (6), p.1545-1551
• Main Authors: Zacchia, Miriam, Blanco, Francesca Del Vecchio, Torella, Annalaura, Raucci, Raffaele, Blasio, Giancarlo, Onore, Maria Elena, Marchese, Emanuela, Trepiccione, Francesco, Vitagliano, Caterina, Iorio, Valentina Di, Alessandra, Perna, Simonelli, Francesca, Nigro, Vincenzo, Capasso, Giovambattista, Viggiano, Davide
• Format: Article
• Language: English
• Subjects: Albumin; Aquaporins; Ethylenediaminetetraacetic acid; Furosemide; Kidney failure; Medical research; Medicine, Experimental; Original
• ISSN: 2048-8505; 2048-8513
• DOI: 10.1093/ckj/sfaa182

Background Urine concentrating defect is a common dysfunction in ciliopathies, even though its underlying mechanism and its prognostic meaning are largely unknown. This study assesses renal function in a cohort of 54 Bardet–Biedl syndrome (BBS) individuals and analyses whether renal hyposthenuria is the result of specific tubule dysfunction and predicts renal disease progression. Methods The estimated glomerular filtration rate (eGFR), urine albumin:creatinine ratio (ACR) and maximum urine osmolality (max-Uosm) were measured in all patients. Genetic analysis was conducted in 43 patients. Annual eGFR decline (ΔeGFR) was measured in patients with a median follow-up period of 6.5 years. Urine aquaporin-2 (uAQP2) excretion was measured and the furosemide test was performed in patients and controls. Results At baseline, 33 (61.1%), 12 (22.2%) and 9 (16.7%) patients showed an eGFR >90, 60–90 and 30 mg/g and 55.8% of patients showed urine concentrating defect in the absence of renal insufficiency. Baseline eGFR, but not max-Uosm, correlated negatively with age. Conversely, truncating mutations affected max-Uosm and showed a trend towards a reduction in eGFR. Max-Uosm correlated with ΔeGFR (P